Veenat 100mg Tablet

Being known as one of the foremost exporters, wholesalers, traders and suppliers, we are offering to our esteemed clients a large stock of Veenat 100mg Tablet by being situated in New Delhi, Delhi, India.

What Imatinib Mesylate Is Used For:
* Newly diagnosed adult and pediatric patients with Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase.
* Ph+ CML in blast crisis, accelerated phase, or chronic phase after failure of interferon-alpha therapy.
* Adult patients with relapsed or refractory Philadelphia chromosome + acute lymphoblastic leukemia (Ph+ ALL).
* Adult patients with myelodysplastic/myeloproliferative diseases (MDS/MPD) associated with PDGFR gene rearrangements.
* Gastrointestinal stromal tumors that are C-kit positive.

Note: If a drug has been approved for one use, physicians may elect to use this same drug for other problems if they believe it may be helpful.

How Imatinib Mesylate Is Given:
* Imatinib mesylate is a pill, taken by mouth, once or twice daily.
* Imatinib mesylate should be taken with a large glass of water, after a meal.
* The amount of Imatinib mesylate that you will receive depends on many factors, including your general health or other health problems, and the type of cancer or condition being treated. Your doctor will determine your dose and schedule.
Side Effects:

Important things to remember about the side effects of Imatinib mesylate:
* Most people do not experience all of the side effects listed.
* Side effects are often predictable in terms of their onset and duration.
* Side effects are almost always reversible and will go away after treatment is complete.
* There are many options to help minimize or prevent side effects.
* There is no relationship between the presence or severity of side effects and the effectiveness of the medication.
* The side effects of Imatinib mesylate and their severity depend on how much of the drug is given. In other words, high doses may produce more severe side effects.
The following side effects are common (occurring in greater than 30%) for patients taking Imatinib mesylate:
* Low blood counts. Your white and red blood cells and platelets may temporarily decrease. This can put you at increased risk for infection, anemia and/or bleeding.
* Nausea and vomiting
* Edema (swelling of the face, feet, hands)
* Muscle cramps and bone pain
* Diarrhea
* Hemorrhage (see bleeding problems)
* Skin rash (see skin reactions)
* Fever

These side effects are less common side effects (occurring in about 10-29%) of patients receiving Imatinib mesylate:
* Headache
* Fatigue
* Joint pain
* Indigestion (see heartburn)
* Abdominal pain
* Cough
* Shortness of breath
* Poor appetite
* Constipation
* Night sweats (see skin reactions)
* Nose bleeds (see bleeding problems)
* Weakness